Glossary
Plain-language glossary.
Definitions for the terms used across Enigma Genetics’ documentation, product, and partner materials.
- Biological trust infrastructure
- Enigma Genetics’ description of the platform: software systems that hold biological data under user-controlled consent, audit, and cryptographic policy.
- Consent-governed access
- An access model in which every read of user data requires explicit, scoped, time-bound, and revocable user consent, enforced by cryptographic policy.
- GeneVault
- Enigma Genetics’ user-controlled vault for genetic and health data. Designed so decryption keys are held on user-controlled hardware.
- 0mnimind
- Enigma Genetics’ AI health companion, pronounced “OmniMind.” Helps users organize, explain, and track genetic and health data over time. Not a medical device.
- Pharmacogenomics
- The study of how genetic variation affects an individual’s response to medications. Common in 0mnimind’s explanatory content.
- Carrier status
- Whether an individual carries a genetic variant associated with an inherited condition. Carrier status reporting in 0mnimind is informational, not diagnostic.
- Post-quantum-ready
- A cryptographic design goal: protecting data using primitives believed to remain secure against quantum-capable adversaries.
- Tamper-evident audit trail
- An append-only log of access events designed so that unauthorized modification is detectable.
- Zero-knowledge architecture
- An architectural design in which the platform operator holds no secrets necessary to read user data. Enigma Genetics targets this property as part of GeneVault’s design.
- Re-identification
- The process of associating de-identified data with a specific individual. Partners and integrations are restricted from attempting re-identification.